Hot Investor Mandate 10: European VC Invests in Therapeutics and Medtech in the Benelux Region

24 Nov

A venture capital firm that was founded in 2005 based in the Netherlands is managing two funds. The firm typically makes equity investments into life science companies at preclinical and clinical stages. The investment size is up to €2.5 million. The firm generally makes 1-3 allocations per year. The firm focuses on companies that are based in the Netherlands and Belgium.

The firm is currently looking for new investment opportunities in Therapeutics, Diagnostics and Medical Devices spaces. The firm is very opportunistic in terms of subsectors and it is interested in Medical Products in the broad sense. The firm also has no restrictions in terms of indications; however, it is most interested in companies with potential for real benefit and/or potential to save healthcare costs. The firm also consider orphan drugs if the business case is good. Historically, the firm was active in medical technology companies developing imaging, surgical instruments and single use devices. The firm was also active in therapeutics and diagnostics companies specializing in drug delivery, biomarker and vaccines.

The firm focuses on investments in private companies and it will consider pre-revenue companies. The firm has no specific requirements for companies’ management team, revenue or EBITDA.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: